This report contains market size and forecasts of Interferon Biosimilar in global, including the following market information:
Global Interferon Biosimilar Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Interferon Biosimilar Market Sales, 2017-2022, 2023-2028, (Kiloton)
Global top five Interferon Biosimilar companies in 2021 (%)
The global Interferon Biosimilar market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Long-lasting Type Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Interferon Biosimilar include Roche, Biosidus, Zydus Cadila, Nanogen, Amega Biotech, Rhein Minapharm Biogenetics, PROBIOMED, 3sbio and Amgen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Interferon Biosimilar manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Interferon Biosimilar Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Interferon Biosimilar Market Segment Percentages, by Type, 2021 (%)
Long-lasting Type
Ordinary Type
Global Interferon Biosimilar Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Interferon Biosimilar Market Segment Percentages, by Application, 2021 (%)
Hepatitis C
Hepatitis B
Other
Global Interferon Biosimilar Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Interferon Biosimilar Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Interferon Biosimilar revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Interferon Biosimilar revenues share in global market, 2021 (%)
Key companies Interferon Biosimilar sales in global market, 2017-2022 (Estimated), (Kiloton)
Key companies Interferon Biosimilar sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Biosidus
Zydus Cadila
Nanogen
Amega Biotech
Rhein Minapharm Biogenetics
PROBIOMED
3sbio
Amgen
Bayer
Schering Plough
Merck